1022-P: Efficacy of Sliding Scale Insulin for Inpatient Glycemic Control in a Multinational Propensity-Matched Cohort Study

1022-P: Efficacy of Sliding Scale Insulin for Inpatient Glycemic Control in a Multinational Propensity-Matched Cohort Study

Sliding scale insulin (SSI) continues to be widely used for glycemic management of inpatients with T2D despite condemnation in clinical guidelines. To confirm the accuracy of this clinical guideline recommendation, we determined the efficacy and safety of using SSI for the management hyperglycemia o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2020-06, Vol.69 (Supplement_1)
Hauptverfasser: MIGDAL, ALEXANDRA, FORTIN, CHARLIE, GUO, YI, HOCHBERG, IRIT, MAGEE, MICHELLE F., PASQUEL, FRANCISCO J., UMPIERREZ, GUILLERMO E.
Format: Artikel
Sprache:eng
Schlagworte:
Acidosis
Bacteremia
Blood glucose
Clinical practice guidelines
Diabetes
Glucose monitoring
Hyperglycemia
Hypoglycemia
Insulin
Lactic acidosis
Patients
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sliding scale insulin (SSI) continues to be widely used for glycemic management of inpatients with T2D despite condemnation in clinical guidelines. To confirm the accuracy of this clinical guideline recommendation, we determined the efficacy and safety of using SSI for the management hyperglycemia of non-critical patients with T2D in a large multinational, propensity-matched cohort study. A total of 53,516 patients with ICD 9/10 code of T2D were included in the dataset. Patients were categorized as having received SSI only vs. basal insulin, and were matched according to age, BMI, Charlson Comorbidity Index, and admission blood glucose (BG). Among patients with admission BG
ISSN:0012-1797
1939-327X
DOI:10.2337/db20-1022-P